Fecal microbiota transplantation for the treatment of Clostridium difficile infection
about
Cytotoxicity of Nanoparticles Contained in Food on Intestinal Cells and the Gut MicrobiotaPatient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection.Nonantimicrobial drug targets for Clostridium difficile infections.Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System.Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.Amelioration of Clostridium difficile Infection in Mice by Dietary Supplementation With Indole-3-carbinol.Microscopic Colitis After Fecal Microbiota Transplant.Long-term microbiota and virome in a Zürich patient after fecal transplantation against Clostridium difficile infection.Upregulation of Intestinal Barrier Function in Mice with DSS-Induced Colitis by a Defined Bacterial Consortium Is Associated with Expansion of IL-17A Producing Gamma Delta T Cells.Emerging Trends in "Smart Probiotics": Functional Consideration for the Development of Novel Health and Industrial ApplicationsCost-Effectiveness of Fecal Microbiota Transplantation in the Treatment of Recurrent Clostridium Difficile Infection: A Literature Review.Treatment With Fecal Microbiota Transplantation: The Need for Complete Methodological Reporting for Clinical Trials.Gut microbiota changes in the extreme decades of human life: a focus on centenarians.Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children.Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.
P2860
Q26750622-8AF12DC0-7806-4522-A71C-66EED93D0A75Q37056524-D664C9D5-A8A3-4E51-A896-9C1A9AC11C9DQ38649348-18EF3FD8-C395-4DD2-85E4-5FCFE3CEC368Q39381331-47A1AD8C-3F59-40DA-845A-1426C2DD7460Q39640585-6889C510-0A6C-4390-87EF-BDF33CC0B467Q39697190-F141CC27-E79B-4AFD-B16A-8D8DD5458D7CQ40111894-38E0094B-64B0-4142-9367-35E7F11187C9Q40708125-92DA70EB-96A5-4D4C-B779-7777CA4D8159Q40987351-B19B8A45-2D59-4D82-BFD6-BC3202432495Q42369781-F6A8A560-2D38-421E-83BF-5D7A912967FEQ42649836-352EF5E8-3D26-4961-B1CA-2C994953EFB4Q47122974-91915334-962B-4A7E-B201-2CC945AEC915Q48018418-E72843F3-ED82-4AF2-85DB-1ACEFC113634Q55004309-ADCA7BD2-8185-4B32-9E6A-E782969B3B7CQ55103812-46FA2198-371E-4C96-A772-AC7D48FFFF63
P2860
Fecal microbiota transplantation for the treatment of Clostridium difficile infection
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Fecal microbiota transplantation for the treatment of Clostridium difficile infection
@ast
Fecal microbiota transplantation for the treatment of Clostridium difficile infection
@en
Fecal microbiota transplantation for the treatment of Clostridium difficile infection
@nl
type
label
Fecal microbiota transplantation for the treatment of Clostridium difficile infection
@ast
Fecal microbiota transplantation for the treatment of Clostridium difficile infection
@en
Fecal microbiota transplantation for the treatment of Clostridium difficile infection
@nl
prefLabel
Fecal microbiota transplantation for the treatment of Clostridium difficile infection
@ast
Fecal microbiota transplantation for the treatment of Clostridium difficile infection
@en
Fecal microbiota transplantation for the treatment of Clostridium difficile infection
@nl
P2860
P3181
P356
P1476
Fecal microbiota transplantation for the treatment of Clostridium difficile infection
@en
P2093
Krishna Rao
Nasia Safdar
P2860
P3181
P356
10.1002/JHM.2449
P407
P577
2016-01-01T00:00:00Z